Cargando…
ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation
BACKGROUND: Hypertrophic cardiomyopathy occurs along with pathological phenomena such as cardiac hypertrophy, myocardial fibrosis and cardiomyocyte activity. However, few of the specific molecular mechanisms underlying this pathological condition have been mentioned. METHODS: All target proteins and...
Autores principales: | Liu, Xin, Lin, Lin, Li, Qing, Ni, Yajuan, Zhang, Chaoying, Qin, Shuguang, Wei, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570861/ https://www.ncbi.nlm.nih.gov/pubmed/31200637 http://dx.doi.org/10.1186/s12860-019-0202-7 |
Ejemplares similares
-
Caveolin-1 Alleviates Acetaminophen—Induced Hepatotoxicity in Alcoholic Fatty Liver Disease by Regulating the Ang II/EGFR/ERK Axis
por: Xin, Jiao, et al.
Publicado: (2022) -
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy
por: Xu, Mingguo, et al.
Publicado: (2022) -
Increased Levels of Phosphorylated ERK Induce CTGF Expression in Autophagy-Deficient Mouse Hepatocytes
por: Seo, Hye-Young, et al.
Publicado: (2022) -
Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020) -
Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)